Drugs for Osteoarthritis Pain Market - Global Outlook and Forecast 2021-2027

March 2021 | 107 pages | ID: D8B19E5D738FEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Drugs for Osteoarthritis Pain in Global, including the following market information:

Global Drugs for Osteoarthritis Pain Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Drugs for Osteoarthritis Pain market was valued at 8983.1 million in 2020 and is projected to reach US$ 11190 million by 2027, at a CAGR of 5.6% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs for Osteoarthritis Pain companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Drugs for Osteoarthritis Pain Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Drugs for Osteoarthritis Pain Market Segment Percentages, By Type, 2020 (%)

• Oral
• Injection
• External

China Drugs for Osteoarthritis Pain Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Drugs for Osteoarthritis Pain Market Segment Percentages, By Application, 2020 (%)

• Medical Care
• Personal Care

Global Drugs for Osteoarthritis Pain Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Drugs for Osteoarthritis Pain Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Drugs for Osteoarthritis Pain Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Drugs for Osteoarthritis Pain Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Pfizer
• Johnson & Johnson
• GlaxoSmithKline
• Bayer
• Eli Lilly
• Novartis
• Sanofi
• Horizon Pharma
• Abbott
• Mylan
• Daiichi Sankyo
• TEVA
• Almatica Pharma
• Astellas Pharma
• Tide Pharmaceutical
• Iroko Pharmaceuticals
• Hengrui Pharmaceutical
• Abiogen Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Drugs for Osteoarthritis Pain Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Drugs for Osteoarthritis Pain Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DRUGS FOR OSTEOARTHRITIS PAIN OVERALL MARKET SIZE

2.1 Global Drugs for Osteoarthritis Pain Market Size: 2021 VS 2027
2.2 Global Drugs for Osteoarthritis Pain Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Drugs for Osteoarthritis Pain Players in Global Market
3.2 Top Global Drugs for Osteoarthritis Pain Companies Ranked by Revenue
3.3 Global Drugs for Osteoarthritis Pain Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Osteoarthritis Pain Companies in Global Market, by Revenue in 2020
3.5 Global Companies Drugs for Osteoarthritis Pain Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Osteoarthritis Pain Players in Global Market
  3.6.1 List of Global Tier 1 Drugs for Osteoarthritis Pain Companies
  3.6.2 List of Global Tier 2 and Tier 3 Drugs for Osteoarthritis Pain Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Drugs for Osteoarthritis Pain Market Size Markets, 2021 & 2027
  4.1.2 Oral
  4.1.3 Injection
  4.1.4 External
4.2 By Type - Global Drugs for Osteoarthritis Pain Revenue & Forecasts
  4.2.1 By Type - Global Drugs for Osteoarthritis Pain Revenue, 2016-2021
  4.2.2 By Type - Global Drugs for Osteoarthritis Pain Revenue, 2022-2027
  4.2.3 By Type - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Drugs for Osteoarthritis Pain Market Size, 2021 & 2027
  5.1.2 Medical Care
  5.1.3 Personal Care
5.2 By Application - Global Drugs for Osteoarthritis Pain Revenue & Forecasts
  5.2.1 By Application - Global Drugs for Osteoarthritis Pain Revenue, 2016-2021
  5.2.2 By Application - Global Drugs for Osteoarthritis Pain Revenue, 2022-2027
  5.2.3 By Application - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Drugs for Osteoarthritis Pain Market Size, 2021 & 2027
6.2 By Region - Global Drugs for Osteoarthritis Pain Revenue & Forecasts
  6.2.1 By Region - Global Drugs for Osteoarthritis Pain Revenue, 2016-2021
  6.2.2 By Region - Global Drugs for Osteoarthritis Pain Revenue, 2022-2027
  6.2.3 By Region - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Drugs for Osteoarthritis Pain Revenue, 2016-2027
  6.3.2 US Drugs for Osteoarthritis Pain Market Size, 2016-2027
  6.3.3 Canada Drugs for Osteoarthritis Pain Market Size, 2016-2027
  6.3.4 Mexico Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Drugs for Osteoarthritis Pain Revenue, 2016-2027
  6.4.2 Germany Drugs for Osteoarthritis Pain Market Size, 2016-2027
  6.4.3 France Drugs for Osteoarthritis Pain Market Size, 2016-2027
  6.4.4 U.K. Drugs for Osteoarthritis Pain Market Size, 2016-2027
  6.4.5 Italy Drugs for Osteoarthritis Pain Market Size, 2016-2027
  6.4.6 Russia Drugs for Osteoarthritis Pain Market Size, 2016-2027
  6.4.7 Nordic Countries Drugs for Osteoarthritis Pain Market Size, 2016-2027
  6.4.8 Benelux Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Drugs for Osteoarthritis Pain Revenue, 2016-2027
  6.5.2 China Drugs for Osteoarthritis Pain Market Size, 2016-2027
  6.5.3 Japan Drugs for Osteoarthritis Pain Market Size, 2016-2027
  6.5.4 South Korea Drugs for Osteoarthritis Pain Market Size, 2016-2027
  6.5.5 Southeast Asia Drugs for Osteoarthritis Pain Market Size, 2016-2027
  6.5.6 India Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Drugs for Osteoarthritis Pain Revenue, 2016-2027
  6.6.2 Brazil Drugs for Osteoarthritis Pain Market Size, 2016-2027
  6.6.3 Argentina Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Drugs for Osteoarthritis Pain Revenue, 2016-2027
  6.7.2 Turkey Drugs for Osteoarthritis Pain Market Size, 2016-2027
  6.7.3 Israel Drugs for Osteoarthritis Pain Market Size, 2016-2027
  6.7.4 Saudi Arabia Drugs for Osteoarthritis Pain Market Size, 2016-2027
  6.7.5 UAE Drugs for Osteoarthritis Pain Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Drugs for Osteoarthritis Pain Major Product Offerings
  7.1.4 Pfizer Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
  7.1.5 Pfizer Key News
7.2 Johnson & Johnson
  7.2.1 Johnson & Johnson Corporate Summary
  7.2.2 Johnson & Johnson Business Overview
  7.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Major Product Offerings
  7.2.4 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
  7.2.5 Johnson & Johnson Key News
7.3 GlaxoSmithKline
  7.3.1 GlaxoSmithKline Corporate Summary
  7.3.2 GlaxoSmithKline Business Overview
  7.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Major Product Offerings
  7.3.4 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
  7.3.5 GlaxoSmithKline Key News
7.4 Bayer
  7.4.1 Bayer Corporate Summary
  7.4.2 Bayer Business Overview
  7.4.3 Bayer Drugs for Osteoarthritis Pain Major Product Offerings
  7.4.4 Bayer Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
  7.4.5 Bayer Key News
7.5 Eli Lilly
  7.5.1 Eli Lilly Corporate Summary
  7.5.2 Eli Lilly Business Overview
  7.5.3 Eli Lilly Drugs for Osteoarthritis Pain Major Product Offerings
  7.5.4 Eli Lilly Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
  7.5.5 Eli Lilly Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis Drugs for Osteoarthritis Pain Major Product Offerings
  7.6.4 Novartis Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
  7.6.5 Novartis Key News
7.7 Sanofi
  7.7.1 Sanofi Corporate Summary
  7.7.2 Sanofi Business Overview
  7.7.3 Sanofi Drugs for Osteoarthritis Pain Major Product Offerings
  7.4.4 Sanofi Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
  7.7.5 Sanofi Key News
7.8 Horizon Pharma
  7.8.1 Horizon Pharma Corporate Summary
  7.8.2 Horizon Pharma Business Overview
  7.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Major Product Offerings
  7.8.4 Horizon Pharma Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
  7.8.5 Horizon Pharma Key News
7.9 Abbott
  7.9.1 Abbott Corporate Summary
  7.9.2 Abbott Business Overview
  7.9.3 Abbott Drugs for Osteoarthritis Pain Major Product Offerings
  7.9.4 Abbott Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
  7.9.5 Abbott Key News
7.10 Mylan
  7.10.1 Mylan Corporate Summary
  7.10.2 Mylan Business Overview
  7.10.3 Mylan Drugs for Osteoarthritis Pain Major Product Offerings
  7.10.4 Mylan Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
  7.10.5 Mylan Key News
7.11 Daiichi Sankyo
  7.11.1 Daiichi Sankyo Corporate Summary
  7.11.2 Daiichi Sankyo Business Overview
  7.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Major Product Offerings
  7.11.4 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
  7.11.5 Daiichi Sankyo Key News
7.12 TEVA
  7.12.1 TEVA Corporate Summary
  7.12.2 TEVA Business Overview
  7.12.3 TEVA Drugs for Osteoarthritis Pain Major Product Offerings
  7.12.4 TEVA Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
  7.12.5 TEVA Key News
7.13 Almatica Pharma
  7.13.1 Almatica Pharma Corporate Summary
  7.13.2 Almatica Pharma Business Overview
  7.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Major Product Offerings
  7.13.4 Almatica Pharma Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
  7.13.5 Almatica Pharma Key News
7.14 Astellas Pharma
  7.14.1 Astellas Pharma Corporate Summary
  7.14.2 Astellas Pharma Business Overview
  7.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Major Product Offerings
  7.14.4 Astellas Pharma Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
  7.14.5 Astellas Pharma Key News
7.15 Tide Pharmaceutical
  7.15.1 Tide Pharmaceutical Corporate Summary
  7.15.2 Tide Pharmaceutical Business Overview
  7.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Major Product Offerings
  7.15.4 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
  7.15.5 Tide Pharmaceutical Key News
7.16 Iroko Pharmaceuticals
  7.16.1 Iroko Pharmaceuticals Corporate Summary
  7.16.2 Iroko Pharmaceuticals Business Overview
  7.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Major Product Offerings
  7.16.4 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
  7.16.5 Iroko Pharmaceuticals Key News
7.17 Hengrui Pharmaceutical
  7.17.1 Hengrui Pharmaceutical Corporate Summary
  7.17.2 Hengrui Pharmaceutical Business Overview
  7.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Major Product Offerings
  7.17.4 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
  7.17.5 Hengrui Pharmaceutical Key News
7.18 Abiogen Pharma
  7.18.1 Abiogen Pharma Corporate Summary
  7.18.2 Abiogen Pharma Business Overview
  7.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Major Product Offerings
  7.18.4 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
  7.18.5 Abiogen Pharma Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Drugs for Osteoarthritis Pain Market Opportunities & Trends in Global Market
Table 2. Drugs for Osteoarthritis Pain Market Drivers in Global Market
Table 3. Drugs for Osteoarthritis Pain Market Restraints in Global Market
Table 4. Key Players of Drugs for Osteoarthritis Pain in Global Market
Table 5. Top Drugs for Osteoarthritis Pain Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Drugs for Osteoarthritis Pain Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Drugs for Osteoarthritis Pain Revenue Share by Companies, 2016-2021
Table 8. Global Companies Drugs for Osteoarthritis Pain Product Type
Table 9. List of Global Tier 1 Drugs for Osteoarthritis Pain Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Osteoarthritis Pain Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Drugs for Osteoarthritis Pain Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Drugs for Osteoarthritis Pain Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Drugs for Osteoarthritis Pain Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Drugs for Osteoarthritis Pain Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Drugs for Osteoarthritis Pain Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Drugs for Osteoarthritis Pain Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2022-2027
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Drugs for Osteoarthritis Pain Product Offerings
Table 32. Pfizer Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Drugs for Osteoarthritis Pain Product Offerings
Table 35. Johnson & Johnson Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline Drugs for Osteoarthritis Pain Product Offerings
Table 38. GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 39. Bayer Corporate Summary
Table 40. Bayer Drugs for Osteoarthritis Pain Product Offerings
Table 41. Bayer Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 42. Eli Lilly Corporate Summary
Table 43. Eli Lilly Drugs for Osteoarthritis Pain Product Offerings
Table 44. Eli Lilly Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 45. Novartis Corporate Summary
Table 46. Novartis Drugs for Osteoarthritis Pain Product Offerings
Table 47. Novartis Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 48. Sanofi Corporate Summary
Table 49. Sanofi Drugs for Osteoarthritis Pain Product Offerings
Table 50. Sanofi Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 51. Horizon Pharma Corporate Summary
Table 52. Horizon Pharma Drugs for Osteoarthritis Pain Product Offerings
Table 53. Horizon Pharma Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 54. Abbott Corporate Summary
Table 55. Abbott Drugs for Osteoarthritis Pain Product Offerings
Table 56. Abbott Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 57. Mylan Corporate Summary
Table 58. Mylan Drugs for Osteoarthritis Pain Product Offerings
Table 59. Mylan Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 60. Daiichi Sankyo Corporate Summary
Table 61. Daiichi Sankyo Drugs for Osteoarthritis Pain Product Offerings
Table 62. Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 63. TEVA Corporate Summary
Table 64. TEVA Drugs for Osteoarthritis Pain Product Offerings
Table 65. TEVA Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 66. Almatica Pharma Corporate Summary
Table 67. Almatica Pharma Drugs for Osteoarthritis Pain Product Offerings
Table 68. Almatica Pharma Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 69. Astellas Pharma Corporate Summary
Table 70. Astellas Pharma Drugs for Osteoarthritis Pain Product Offerings
Table 71. Astellas Pharma Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 72. Tide Pharmaceutical Corporate Summary
Table 73. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product Offerings
Table 74. Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 75. Iroko Pharmaceuticals Corporate Summary
Table 76. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product Offerings
Table 77. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 78. Hengrui Pharmaceutical Corporate Summary
Table 79. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product Offerings
Table 80. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 81. Abiogen Pharma Corporate Summary
Table 82. Abiogen Pharma Drugs for Osteoarthritis Pain Product Offerings
Table 83. Abiogen Pharma Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Drugs for Osteoarthritis Pain Segment by Type
Figure 2. Drugs for Osteoarthritis Pain Segment by Application
Figure 3. Global Drugs for Osteoarthritis Pain Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Drugs for Osteoarthritis Pain Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Drugs for Osteoarthritis Pain Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drugs for Osteoarthritis Pain Revenue in 2020
Figure 8. By Type - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 9. By Application - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 10. By Region - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 11. By Country - North America Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 12. US Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 16. Germany Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 17. France Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 24. China Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 28. India Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 30. Brazil Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 33. Turkey Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 37. Pfizer Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Johnson & Johnson Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Bayer Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Eli Lilly Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Novartis Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Sanofi Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Horizon Pharma Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Abbott Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Mylan Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. TEVA Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Almatica Pharma Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Astellas Pharma Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Abiogen Pharma Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)